Merck (MRK) is reportedly planning to double the production of molnupiravir, an antiviral COVID pill, next year. The Financial Times reported the drugmaker has secured deals to provide COVID ...

The US has also ordered 3.1 million doses of molnupiravir for around $2.2 billion. Merck – which is developing the drug with Ridgeback Biotherapeutics – is one step ahead for a regulatory ...

The US government has placed an order with Merck & Co to buy 1.7 million courses of its antiviral therapy molnupiravir for COVID-19, assuming it gets approved for use by the FDA. The $1.2 billion ...

While Merck's oral drug Molnupiravir has already been cleared by the United Kingdom to treat COVID-19, a Paraguayan laboratory has filed for its emergency registration in the South American ...

The new anti-viral drug brought out by Merck Pharmaceuticals, Molnupiravir, seems to be a promising development in the global fight against COVID-19. Early results from the phase-3 trial of the ...

Molnupiravir was developed by Merck, Sharp and Dohme and Ridgeback Biotherapeutics. Merck explained that in clinical trials, Molnupiravir was administered to 775 patients who had recently been ...

Merck & Co., Inc. (MRK) Jefferies London Healthcare Conference Merck reports positive Phase 2 data for zilovertamab vedotin Merck begins trial of molnupiravir for COVID-19 with high risk of ...

Merck's drug was far less effective in a late ... The FDA said on Thursday that molnupiravir is not recommended for pregnant people. "As a woman of child-bearing age, I don't think I would want ...

Merck MRK reported fourth-quarter 2024 adjusted earnings per share (EPS) of $1.72, which beat the Zacks Consensus Estimate of $1.69. In the year-ago period, management reported adjusted EPS of 3 cents ...

Amid the ongoing resurgence of new Covid-19 cases in India, an expert panel of the Central Drugs Standard Control Organisation on Tuesday approved Merck's anti-viral drug molnupiravir for ...

Merck agrees to allow Sinopharm to sell molnupiravir COVID drug in China The drugmaker said in a statement that it reached a cooperation framework agreement with Sinopharm that grants the Chinese ...